Agenus Inc. (AGEN) vs Ocugen, Inc. (OCGN)
- Agenus Inc. AGEN 6.04 −9.58%
- Ocugen, Inc. OCGN 0.78 −3.70%
Agenus Inc. and Ocugen, Inc. are both Biotechnology companies. Agenus Inc. and Ocugen, Inc. are of similar size ($301.7M and $275.9M). Ocugen, Inc. has negative trailing earnings, so its P/E is not meaningful; Agenus Inc. trades at 2.3×. Agenus Inc. grew revenue faster over the last twelve months: 30.5% against −3.66%. Agenus Inc. has the higher net margin (69.2% vs −1,786.3%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, Agenus Inc. leads on 11 and Ocugen, Inc. on 4.
Valuation
Profitability
| Metric | AGEN | OCGN | Biotechnology median |
|---|---|---|---|
| Gross margin | 99.52% | 100.00% | 65.16% |
| Operating margin | 27.28% | (1,504.43%) | 0.00% |
| Net margin | 69.18% | (1,786.27%) | 0.00% |
| Free cash flow margin | (73.97%) | (1,332.36%) | 0.00% |
| Return on equity | (33.86%) | 1,211.66% | (56.36%) |
| Return on assets | 51.30% | (92.03%) | (48.04%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack